Clyde Yancy
#58,442
Most Influential Person Now
American cardiologist
Clyde Yancy's AcademicInfluence.com Rankings
Clyde Yancyphilosophy Degrees
Philosophy
#2885
World Rank
#4787
Historical Rank
Logic
#835
World Rank
#1387
Historical Rank
Download Badge
Philosophy
Why Is Clyde Yancy Influential?
(Suggest an Edit or Addition)According to Wikipedia, Clyde Warren Yancy is an American cardiologist and the Magerstadt Professor at Northwestern University Feinberg School of Medicine. He has previously served as the Past President of the American Heart Association. His research considers heart failure, heart transplantation and ways to prevent heart failure. He is Vice Dean of Diversity and Inclusion.
Clyde Yancy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (9561)
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014) (5351)
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (5272)
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013) (3504)
- Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond (2010) (3237)
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. (2014) (2679)
- 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (2552)
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (2433)
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (2315)
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014) (2287)
- 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (1905)
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1845)
- Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. (2004) (1595)
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker (2008) (1569)
- COVID-19 and African Americans. (2020) (1549)
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2019) (1541)
- ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007) (1400)
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017) (1330)
- 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008) (1319)
- 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2010) (1269)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) (1257)
- Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. (2005) (1245)
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary (2010) (1162)
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2019) (1088)
- ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation (2007) (1064)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci (2011) (1054)
- Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. (2007) (1041)
- 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (1008)
- Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. (2006) (976)
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. (2019) (965)
- Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. (2010) (964)
- 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (927)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) (904)
- 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (889)
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (888)
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (880)
- 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. (2008) (872)
- ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemaker (2008) (866)
- 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (847)
- Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association (2015) (817)
- State of the art: Using natriuretic peptide levels in clinical practice (2008) (780)
- Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. (2006) (738)
- Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction (2015) (696)
- 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention (2013) (682)
- ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults (2010) (636)
- Cocaine-induced coronary-artery vasoconstriction. (1989) (593)
- 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (590)
- Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association (2017) (554)
- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. (2017) (554)
- Cardiorenal interactions: insights from the ESCAPE trial. (2008) (552)
- Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. (2007) (547)
- Association between performance measures and clinical outcomes for patients hospitalized with heart failure. (2007) (535)
- Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2008) (531)
- Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. (2011) (519)
- Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. (2020) (501)
- 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. (2021) (468)
- Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. (2008) (467)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (467)
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. (2016) (445)
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (426)
- Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2008) (405)
- Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). (2007) (403)
- Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure (2021) (395)
- Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. (2007) (393)
- Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) (2010) (381)
- Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease (2010) (378)
- 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (377)
- BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. (2004) (376)
- ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angi (2008) (369)
- Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association (2017) (367)
- Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. (2004) (341)
- Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. (1995) (340)
- Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis (2005) (329)
- Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure (2017) (328)
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (321)
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (317)
- A Taxonomy for Disease Management: A Scientific Statement From the American Heart Association Disease Management Taxonomy Writing Group (2006) (301)
- Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. (2001) (286)
- Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. (2014) (285)
- Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. (2005) (283)
- Gender differences in advanced heart failure: insights from the BEST study. (2003) (280)
- Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). (2007) (267)
- Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. (2021) (263)
- Use of aldosterone antagonists in heart failure. (2009) (263)
- 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2012) (256)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (250)
- Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. (2012) (239)
- 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (233)
- Prediction of 30-Day All-Cause Readmissions in Patients Hospitalized for Heart Failure: Comparison of Machine Learning and Other Statistical Approaches (2017) (232)
- 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (2018) (229)
- Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. (2016) (229)
- Thrombosis in Coronary Drug-Eluting Stents: Report From the Meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006* (2007) (212)
- Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. (2011) (210)
- 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2012) (208)
- Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction. (2016) (206)
- 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (204)
- Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF (2008) (198)
- 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (197)
- How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda. (2013) (196)
- Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. (2006) (193)
- Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2007) (186)
- Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. (2008) (182)
- Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). (2008) (173)
- 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive summary (2011) (162)
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (161)
- Health literacy and the patient with heart failure--implications for patient care and research: a consensus statement of the Heart Failure Society of America. (2010) (159)
- 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary (2012) (149)
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (145)
- Central venous pressure in space. (1993) (145)
- Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. (2002) (143)
- Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward (2010) (141)
- Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. (2016) (139)
- 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 guideline) (2012) (138)
- Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry. (2015) (137)
- ACCF/AHA Clinical Practice Guideline Methodology Summit Report: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (136)
- Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. (2013) (132)
- Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions. (2008) (130)
- Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. (2009) (129)
- Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. (2012) (128)
- Physical fitness and cardiovascular regulation: mechanisms of orthostatic intolerance. (1991) (128)
- Get With The Guidelines Program Participation, Process of Care, and Outcome for Medicare Patients Hospitalized With Heart Failure (2012) (124)
- Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. (2004) (123)
- Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. (2007) (118)
- Recalibrating the Use of Race in Medical Research. (2021) (118)
- Trends in Use of Implantable Cardioverter-Defibrillator Therapy Among Patients Hospitalized for Heart Failure: Have the Previously Observed Sex and Racial Disparities Changed Over Time? (2012) (117)
- Incremental Value of Clinical Data Beyond Claims Data in Predicting 30-Day Outcomes After Heart Failure Hospitalization (2011) (116)
- Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review. (2019) (115)
- Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). (2009) (112)
- Heart failure in African Americans. (2005) (112)
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (112)
- Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. (2008) (111)
- Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). (2009) (111)
- Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial). (2004) (111)
- Heart failure in African Americans: a cardiovascular engima. (2000) (111)
- Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2007) (111)
- Dietary Sodium Intake in Heart Failure (2012) (109)
- Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. (2009) (107)
- Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. (2005) (107)
- Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial. (2009) (107)
- Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure. (2002) (107)
- Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. (2009) (106)
- Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines–Heart Failure Registry (2018) (106)
- Noninvasive hemodynamic monitoring in heart failure: utilization of impedance cardiography. (2003) (105)
- ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (103)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (103)
- Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry. (2016) (102)
- Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction (2017) (101)
- Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF). (2017) (99)
- Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial (2007) (99)
- African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. (2002) (98)
- The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. (2011) (98)
- Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis. (2016) (97)
- Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure (2008) (96)
- Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. (2008) (96)
- Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. (2011) (90)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (90)
- Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial. (2016) (89)
- Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF (2012) (88)
- Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project. (2016) (88)
- Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure. (2016) (88)
- Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. (1996) (87)
- Associations Between Outpatient Heart Failure Process-of-Care Measures and Mortality (2011) (86)
- Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition (2017) (86)
- The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. (2011) (85)
- Clinical outcomes after cardiac transplantation in muscular dystrophy patients. (2007) (85)
- Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: executive summary. (2005) (84)
- Weekend hospital admission and discharge for heart failure: association with quality of care and clinical outcomes. (2009) (83)
- ACC/AHA 2008 Guideline Update on Valvular Heart Disease: Focused Update on Infective Endocarditis (2008) (83)
- Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). (2008) (82)
- The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider. (2017) (80)
- Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease (2013) (80)
- Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. (2009) (78)
- Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study. (2008) (78)
- Short‐ and Long‐term Rehospitalization and Mortality for Heart Failure in 4 Racial/Ethnic Populations (2014) (78)
- Hydralazine and Isosorbide Dinitrate in Heart Failure: Historical Perspective, Mechanisms, and Future Directions (2011) (77)
- Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program (2016) (76)
- ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. (2010) (76)
- Comparison of Medical Therapy Dosing in Outpatients Cared for in Cardiology Practices With Heart Failure and Reduced Ejection Fraction With and Without Device Therapy: Report From IMPROVE HF (2010) (76)
- 10-Year Risk Equations for Incident Heart Failure in the General Population. (2019) (76)
- The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial. (2013) (75)
- Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure—Reply (2005) (73)
- The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. (2007) (72)
- Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization (2015) (72)
- Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure (2010) (71)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) (71)
- Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: A report from OPTIMIZE‐HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) * (2008) (71)
- ACCF/AHA Focused Update 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (2011) (71)
- Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes. (2016) (71)
- Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart Failure: Findings From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) (2008) (70)
- Translating Evidence Into Practice: A Decade of Efforts by the American Heart Association/American Stroke Association to Reduce Death and Disability Due to Stroke: A Presidential Advisory From the American Heart Association/American Stroke Association (2010) (69)
- Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. (2012) (69)
- Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. (2007) (69)
- Population Risk Prediction Models for Incident Heart Failure: A Systematic Review (2015) (69)
- Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. (2013) (67)
- Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial. (2004) (67)
- Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. (2008) (66)
- Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. (2020) (65)
- Heart failure in African Americans: Disparities can be overcome (2014) (65)
- Association of Arginine Vasopressin Levels With Outcomes and the Effect of V2 Blockade in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction: Insights From the EVEREST Trial (2013) (65)
- Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction (2018) (65)
- The American Heart Association’s 2008 Statement of Principles for Healthcare Reform (2008) (64)
- Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF). (2009) (64)
- Utility of Socioeconomic Status in Predicting 30-Day Outcomes After Heart Failure Hospitalization (2015) (63)
- The Need for Multiple Measures of Hospital Quality: Results From the Get With The Guidelines–Heart Failure Registry of the American Heart Association (2011) (63)
- Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. (1995) (63)
- Relationships between emerging measures of heart failure processes of care and clinical outcomes. (2010) (61)
- Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure. (2014) (60)
- Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter? (2020) (59)
- Safety and Efficacy of Outpatient Nesiritide in Patients With Advanced Heart FailureCLINICAL PERSPECTIVE (2008) (59)
- Noninvasive assessment of hemodynamics: an emphasis on bioimpedance cardiography. (2000) (58)
- Eliminating racial and ethnic disparities in cardiac care. (2009) (57)
- Home-Time After Discharge Among Patients Hospitalized With Heart Failure. (2018) (57)
- Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines—Heart Failure (2019) (57)
- Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. (2008) (57)
- A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF. (2008) (57)
- World Heart Federation Roadmap for Heart Failure. (2019) (57)
- In‐hospital worsening heart failure (2015) (57)
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure. (2020) (55)
- Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days. (2013) (55)
- Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy. (2015) (55)
- Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation. (2019) (55)
- Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. (2009) (54)
- Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care. (2010) (53)
- Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. (2009) (53)
- Medication dosing for heart failure with reduced ejection fraction — opportunities and challenges (2018) (52)
- Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry. (2018) (52)
- Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. (2008) (51)
- Length of hospital stay and 30‐day readmission following heart failure hospitalization: insights from the EVEREST trial (2015) (51)
- Hormone replacement therapy is associated with improved survival in women with advanced heart failure. (2003) (51)
- Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. (2009) (51)
- Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals (2018) (51)
- Trial characteristics associated with under‐enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review (2020) (50)
- The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations. (2019) (50)
- Worldwide disparities in cardiovascular disease: Challenges and solutions. (2016) (49)
- Characteristics and outcomes in African American patients with decompensated heart failure. (2008) (49)
- Antibodies Against Donor Human Leukocyte Antigens and the Outcome of Cardiac Allografts in Adults and Children (2007) (49)
- Kidney Function and Outcomes in Patients Hospitalized with Heart Failure. (2021) (48)
- Academic Medicine and Black Lives Matter: Time for Deep Listening. (2020) (47)
- Treatment of heart failure in African Americans: a consensus statement. (2010) (46)
- 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2020) (46)
- Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module). (2008) (45)
- Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). (2010) (45)
- Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction (2016) (45)
- Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation Among Patients Hospitalized With Heart Failure (2013) (44)
- Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. (2010) (44)
- HFSA 2010 Guideline Executive Summary Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline (2006) (44)
- Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart FailureCLINICAL PERSPECTIVE (2008) (44)
- Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient—part 1 (2009) (44)
- Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. (2005) (44)
- The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design. (2007) (44)
- Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. (2011) (44)
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (43)
- Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). (2009) (42)
- Cardiology and COVID-19. (2020) (42)
- The natural history, epidemiology, and prognosis of heart failure in African Americans. (2004) (42)
- Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines–Heart Failure Program (2017) (41)
- The heart failure and sodium restriction controversy: challenging conventional practice. (2008) (41)
- The American Heart Association’s Principles for Comparative Effectiveness Research: A Policy Statement From the American Heart Association (2009) (40)
- Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. (2017) (40)
- Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. (2008) (40)
- Quality of care and outcomes in acute decompensated heart failure: The ADHERE registry (2004) (39)
- Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines–Heart Failure Registry (2018) (39)
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. (2020) (39)
- G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT. (2014) (39)
- Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial). (2006) (39)
- 2016 ESC and ACC/AHA/HFSA heart failure guideline update — what is new and why is it important? (2016) (38)
- Clinical Effectiveness of Cardiac Resynchronization and Implantable Cardioverter-Defibrillator Therapy in Men and Women With Heart Failure: Findings From IMPROVE HF (2014) (38)
- Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis. (2008) (38)
- Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease (2017) (37)
- High‐dose influenza vaccine to reduce clinical outcomes in high‐risk cardiovascular patients: Rationale and design of the INVESTED trial☆☆ (2018) (37)
- Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial. (2021) (37)
- Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF. (2007) (36)
- Effects of early steroid withdrawal after heart transplantation. (2006) (36)
- Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program (2019) (35)
- ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training. (2010) (35)
- Does race matter in heart failure? (2003) (35)
- Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. (2016) (35)
- Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). (2009) (35)
- Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction (2013) (35)
- Electronic health records and quality of care for heart failure. (2010) (35)
- Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure (2018) (34)
- Nitrate therapy for heart failure: benefits and strategies to overcome tolerance. (2013) (33)
- Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment. (2008) (33)
- Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. (2014) (33)
- Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care (2007) (33)
- Role of atrial natriuretic peptide in systemic responses to acute isotonic volume expansion. (1992) (33)
- AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy : Executive summary (2011) (32)
- 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2020) (32)
- Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. (2018) (32)
- Temporal Trends and Variation in Early Scheduled Follow-Up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure (2016) (32)
- Heart failure in African Americans: pathophysiology and treatment. (2003) (31)
- Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure. (2016) (30)
- Posttraumatic Stress Disorder and Cardiovascular Disease: State of the Science, Knowledge Gaps, and Research Opportunities. (2021) (30)
- Health-related quality of life in mechanical circulatory support: Development of a new conceptual model and items for self-administration. (2015) (30)
- Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women (2016) (30)
- Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success. (2019) (29)
- Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines–Heart Failure Registry (2018) (29)
- Association of Physical Activity or Fitness With Incident Heart Failure: A Systematic Review and Meta-Analysis. (2015) (29)
- Endpoints in Heart Failure Drug Development: History and Future. (2020) (29)
- A common variant alters SCN5A–miR-24 interaction and associates with heart failure mortality (2018) (28)
- Hyperkalemia, congestive heart failure, and aldosterone receptor antagonism. (2003) (28)
- Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry. (2020) (28)
- Heart Failure with Preserved Ejection Fraction in Women. (2019) (28)
- Clinical Effectiveness of Hydralazine–Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry (2016) (27)
- 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2017) (27)
- Patient and hospital characteristics associated with traditional measures of inpatient quality of care for patients with heart failure. (2012) (27)
- Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. (2010) (27)
- Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes. (2010) (27)
- Influence of hospital length of stay for heart failure on quality of care. (2008) (27)
- Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management. (2004) (27)
- 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary (2022) (27)
- Transthoracic impedance cardiography: a noninvasive method of hemodynamic assessment. (2009) (26)
- Association of the Affordable Care Act’s Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure (2018) (26)
- Temporal Trends and Factors Associated With Cardiac Rehabilitation Participation Among Medicare Beneficiaries With Heart Failure. (2021) (26)
- Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19 (2020) (26)
- Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. (2001) (26)
- Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF. (2019) (26)
- FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study (2018) (26)
- Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention (2014) (25)
- Preparedness and Mutuality Affect Quality of Life for Patients With Mechanical Circulatory Support and Their Caregivers: A Qualitative Analysis (2019) (25)
- Diversity in Medical Schools-Need for a New Bold Approach. (2021) (25)
- Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). (2017) (25)
- Shock – Classification and Pathophysiological Principles of Therapeutics (2019) (25)
- Health insurance and cardiac transplantation: a call for reform. (2005) (24)
- Heart Failure and Sudden Cardiac Death. (2017) (24)
- Climbing the mountain of acute decompensated heart failure: the EVEREST Trials. (2007) (24)
- Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). (2010) (24)
- Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes (2017) (24)
- Heart Transplantation: An In-Depth Survival Analysis. (2020) (24)
- American Heart Association and Nonprofit Advocacy: Past, Present, and Future: A Policy Recommendation From the American Heart Association (2011) (24)
- Treatment of hyperlipidemia after heart transplantation and rationale for the Heart Transplant Lipid Registry. (1996) (24)
- Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators. (2015) (24)
- Treatment with B-Type Natriuretic Peptide for Chronic Decompensated Heart Failure: Insights Learned from the Follow-Up Serial Infusion of Nesiritide (FUSION) Trial (2005) (23)
- Comprehensive treatment of heart failure: state-of-the-art medical therapy. (2005) (23)
- Adherence to Heart Failure Quality-of-Care Indicators in US Hospitals. Analysis of the ADHERE Registry (2005) (23)
- The prevention of heart failure in minority communities and discrepancies in health care delivery systems. (2004) (23)
- Secondary surgical‐site infection after coronary artery bypass grafting: A multi‐institutional prospective cohort study (2017) (23)
- Beyond diuretics: management of volume overload in acute heart failure syndromes. (2006) (22)
- A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure. (2013) (22)
- Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). (2010) (22)
- Lack of Association Between Electronic Health Record Systems and Improvement in Use of Evidence‐Based Heart Failure Therapies in Outpatient Cardiology Practices (2012) (22)
- Heart failure in blacks: Etiologic and epidemiologic differences (2001) (22)
- Impaired Cardiac Function and Cognitive Brain Aging. (2017) (22)
- Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies. (2010) (21)
- Pharmacologic therapies across the continuum of left ventricular dysfunction. (2008) (21)
- The role of race in heart failure therapy (2002) (21)
- Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients. (2020) (21)
- Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality (2019) (21)
- Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction. (2018) (21)
- Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program. (2011) (21)
- Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care. (2004) (20)
- 2022 ACC Health Policy Statement on Building Respect, Civility, and Inclusion in the Cardiovascular Workplace: A Report of the American College of Cardiology Solution Set Oversight Committee. (2022) (20)
- Current approaches to monitoring and management of heart failure. (2006) (20)
- Incident heart failure in relation to vascular disease: Insights from the Health, Aging, and Body Composition Study (2014) (20)
- Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease (2016) (20)
- Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. (2001) (20)
- Pediatric Heart Transplantation: Transitioning to Adult Care (TRANSIT) Feasibility of a Pilot Randomized Controlled Trial. (2018) (20)
- Systolic time ratio by impedance cardiography to distinguish preserved vs impaired left ventricular systolic function in heart failure. (2008) (20)
- Pre-Ventricular Assist Device Palliative Care Consultation: A Qualitative Analysis. (2019) (19)
- Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations. (2020) (19)
- Contemporary Approaches to Patients with Heart Failure. (2017) (18)
- Patient Perceptions and Familiarity With Medical Therapy for Heart Failure. (2019) (18)
- Sex Differences in Heart Failure. (2021) (18)
- Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines–Heart Failure (2016) (18)
- Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure. (2021) (18)
- Association of State Medicaid Expansion With Rate of Uninsured Hospitalizations for Major Cardiovascular Events, 2009-2014 (2018) (17)
- Equity and the JAMA Network. (2021) (17)
- Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation (2012) (17)
- Heart Failure-A New Phenotype Emerges. (2016) (17)
- Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure (2015) (17)
- Trends in the Prevalence of Self-reported Heart Failure by Race/Ethnicity and Age From 2001 to 2016. (2020) (17)
- Racial differences in heart failure therapeutics. (2010) (17)
- Echocardiographic markers of left ventricular unloading using a centrifugal-flow rotary pump. (2014) (17)
- Insights From the ESCAPE Trial (2008) (16)
- Usefulness of Coronary Artery Calcium to Predict Heart Failure With Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis). (2017) (16)
- Site selection for heart failure clinical trials in the USA (2015) (16)
- Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. (2016) (16)
- Management of patients with congestive heart failure after hospitalization: results from the follow up serial infusions of nesiritide (FUSION) trial (2003) (16)
- Evaluation of Risk-Adjusted Home Time After Hospitalization for Heart Failure as a Potential Hospital Performance Metric. (2020) (16)
- Reproducibility and observer variability of tissue phase mapping for the quantification of regional myocardial velocities (2016) (16)
- Cardiac Structure–Function MRI in Patients After Heart Transplantation (2019) (16)
- Baseline Longitudinal Strain Predicts Recovery of Left Ventricular Ejection Fraction in Hospitalized Patients With Nonischemic Cardiomyopathy (2018) (16)
- Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines—Heart Failure (2018) (16)
- Extracellular Volume Fraction Is More Closely Associated With Altered Regional Left Ventricular Velocities Than Left Ventricular Ejection Fraction in Nonischemic Cardiomyopathy (2014) (16)
- Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19 (2021) (16)
- Factors Associated with Improvement in Guideline‐Based Use of ICDs in Eligible Heart Failure Patients (2012) (15)
- 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention (2008) (15)
- Is coronary computed tomography angiography a resource sparing strategy in the risk stratification and evaluation of acute chest pain? Results of a randomized controlled trial. (2011) (15)
- Equity and the JAMA Network. (2021) (15)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. (2012) (15)
- Long‐term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines–Heart Failure Registry (2019) (15)
- Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions (2018) (15)
- Heart failure in African Americans: unique etiology and pharmacologic treatment responses. (2003) (14)
- Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment. (2013) (14)
- Concentric left ventricular hypertrophy as assessed by cardiac magnetic resonance imaging and risk of death in cardiac transplant recipients. (2010) (14)
- Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. (2019) (14)
- Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction (2020) (14)
- Survival in congestive heart failure: have we made a difference? (1990) (14)
- Association of Physical Activity or Fitness With Incident Heart FailureCLINICAL PERSPECTIVE (2015) (14)
- Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention (2015) (14)
- Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. (2021) (14)
- The Uncertainty of Sodium Restriction in Heart Failure: We Can Do Better Than This. (2016) (13)
- Pediatric Heart Transplantation: Transitioning to Adult Care (TRANSIT): Baseline Findings (2018) (13)
- Predicting life expectancy in heart failure. (2008) (13)
- 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. (2021) (13)
- Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations (2017) (13)
- Is ideal cardiovascular health attainable? (2011) (12)
- Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial). (2007) (12)
- Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure (2006) (12)
- Race and the natural history of chronic heart failure: a propensity-matched study. (2008) (12)
- Cost-effectiveness of PCSK9 Inhibitors: Proof in the Modeling. (2017) (12)
- Stopping medication for heart failure with improved ejection fraction (2019) (12)
- Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials. (2004) (12)
- Cardiovascular Disease in African Americans (2004) (12)
- Advancing Healthcare Reform: The American Heart Association’s 2020 Statement of Principles for Adequate, Accessible, and Affordable Health Care: A Presidential Advisory From the American Heart Association (2020) (12)
- Variation in heart failure quality of care indicators among U.S. hospitals: analysis of 230 hospitals in the ADHERE registry (2003) (12)
- Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America (2021) (12)
- Executive summary of the African-American Initiative. (2007) (12)
- Availability and Use of Shared Data From Cardiometabolic Clinical Trials (2017) (12)
- 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. (2021) (12)
- Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfunction Prevention trial). (2005) (12)
- Diet prevention and therapy for heart failure? (2013) (12)
- Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure (2016) (12)
- Trends in Place of Death for Cardiovascular Mortality Related to Heart Failure in the United States From 2003 to 2017 (2020) (11)
- Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. (2021) (11)
- Sodium Restriction in Heart Failure: Too Much Uncertainty-Do the Trials. (2018) (11)
- Risk-Based Approach for the Prediction and Prevention of Heart Failure. (2021) (11)
- Age Differences in the Use of Implantable Cardioverter‐Defibrillators Among Older Patients Hospitalized with Heart Failure (2013) (11)
- Correction to 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2017) (11)
- Characteristics, quality of care, and in-hospital outcomes of Asian-American heart failure patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program. (2015) (11)
- Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure (2007) (11)
- Fibroblast Growth Factor-23, Heart Failure Risk, and Renin–Angiotensin–Aldosterone-System Blockade in Hypertension: The MESA Study (2018) (11)
- Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients. (2019) (11)
- Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice. (2011) (11)
- Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory. (2022) (11)
- Characteristics of Acute Heart Failure Hospitalizations Based on Presenting Severity: Findings From the Get With the Guidelines–Heart Failure Registry (2019) (11)
- A Hospital Level Analysis of 30‐Day Readmission Performance for Heart Failure Patients and Long‐Term Survival: Findings from Get With The Guidelines‐Heart Failure (2018) (10)
- Incorporating Patient and Caregiver Experiences Into Cardiovascular Clinical Trial Design (2017) (10)
- Predictive Accuracy of Heart Failure-Specific Risk Equations in an Electronic Health Record-Based Cohort (2020) (10)
- Strokes associated with left ventricular assist devices (2018) (10)
- Is impedance cardiography-derived systolic time ratio a useful method to determine left ventricular systolic dysfunction in heart failure? (2004) (10)
- Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT). (2020) (10)
- Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines–Heart Failure Registry (2021) (10)
- Primary Prevention Implantable Cardioverter-Defibrillators in Older Racial and Ethnic Minority Patients (2015) (10)
- Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (2019) (10)
- Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working. (2021) (10)
- Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure). (2019) (10)
- ECG--still the best for selecting patients for CRT. (2013) (10)
- Vasodilator therapy for decompensated heart failure. (2008) (10)
- Primer on Biomarker Discovery in Cardio-Oncology (2020) (10)
- Using homeostatic peptides in decompensated heart failure a reasonable paradigm but a flawed practice? (2007) (10)
- Heart Failure Risk Distribution and Trends in the United States Population, NHANES 1999-2016. (2020) (10)
- Distribution in Place of Death for COVID‐19–Related Mortality in the United States (2020) (9)
- Geographic Variation in Trends and Disparities in Heart Failure Mortality in the United States, 1999 to 2017 (2021) (9)
- Timing of Postdischarge Follow‐Up and Medication Adherence Among Patients With Heart Failure (2018) (9)
- Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy. (2017) (9)
- Impact of an Expanded Hospital Recognition Program for Heart Failure Quality of Care (2014) (9)
- Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association (2022) (9)
- Beyond Disease Reduction : The American Heart Association ’ s Strategic Impact Goal Defining and Setting National Goals for Cardiovascular Health Promotion (2010) (9)
- A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004. (2008) (9)
- Decompensated heart failure: is there a role for the outpatient use of nesiritide? (2004) (9)
- Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival. (2005) (9)
- Racial response to angiotensin-converting enzyme therapy in systolic heart failure. (2004) (9)
- Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function. (2017) (9)
- Thrombosis in Coronary Drug-Eluting Stents (2007) (9)
- Improving Care for Heart Failure With Reduced Ejection Fraction-A Potential Polypill-Based Strategy. (2020) (9)
- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction (9)
- Personalized medicine in heart failure: are we there yet? (2012) (9)
- Novel therapies for heart failure: vasopressin and selective aldosterone antagonists. (2005) (8)
- Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. (2012) (8)
- Factors Associated with Improvement in Utilization of Cardiac Resynchronization Therapy in Eligible Heart Failure Patients: Findings from IMPROVE HF (2013) (8)
- Heart failure medications prescribed at discharge for patients with left ventricular assist devices. (2016) (8)
- HFSA Position Statement The Impact of Healthcare Disparities on Patients with Heart Failure. (2022) (8)
- Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers. (2015) (8)
- Heart failure therapy in special populations: the same or different? (2004) (8)
- 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (2017) (8)
- A HOSPITAL LEVEL ANALYSIS OF 30-DAY READMISSION RATES FOR HEART FAILURE PATIENTS AND LONG-TERM SURVIVAL AMONG HIGHEST AND LOWEST PERFORMING HOSPITALS, FINDINGS FROM GET WITH THE GUIDELINES-HEART FAILURE (2017) (8)
- 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (2022) (8)
- Combined thrombolytic therapy for prosthetic mitral valve thrombosis. (1993) (8)
- Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). (2019) (8)
- Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure (2020) (8)
- The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease. (2008) (8)
- Optimizing the Potential for Telehealth in Cardiovascular Care (in the Era of COVID-19): Time Will Tell (2021) (8)
- A bald fade and a BP check: Comment on "Effectiveness of a barbershop-based intervention for improving hypertension control in black men". (2011) (8)
- Association of Dual Eligibility for Medicare and Medicaid With Heart Failure Quality and Outcomes Among Get With The Guidelines-Heart Failure Hospitals. (2021) (8)
- Race-based therapeutics (2008) (7)
- Cardiovascular Care in an Increasingly Diverse Community (2012) (7)
- Heart Failure With Reduced Ejection Fraction (2021) (7)
- Clinical trials of β-blockers in heart failure: a class review (2001) (7)
- Reform The American Heart Association's 2008 Statement of Principles for Healthcare (2008) (7)
- Assessment of the quality of existing patient educational tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance (2013) (7)
- The Need for Multiple Measures of Hospital QualityClinical Perspective (2011) (7)
- AHA / ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death (7)
- Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes. (2011) (7)
- Universal Definition and Classification of Heart Failure Is it universal? Does it define heart failure? (2021) (7)
- Heart failure in African Americans: a cardiovascular enigma now resolved? (2005) (7)
- patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). (2011) (7)
- Consequences of Reductions in Hospital Readmissions. (2017) (7)
- Leveraging electronic health record documentation for Failure Mode and Effects Analysis team identification (2016) (7)
- Advances in the management of acute and chronic decompensated heart failure. (2004) (7)
- Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study. (2020) (7)
- Heart failure quality of care and in‐hospital outcomes during the COVID‐19 pandemic: findings from the Get With The Guidelines‐Heart Failure registry (2022) (6)
- Targeting the Correct Population When Designing Transitional Care Programs for Medicare Patients Hospitalized With Heart Failure (2017) (6)
- Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7. (2022) (6)
- The use of beta-adrenergic receptor antagonists in the treatment of African Americans with heart failure. (2004) (6)
- Practical Considerations for BNP Use (2003) (6)
- Treatment of the african-american patient with congestive heart failure (2005) (6)
- The editor's roundtable: B-type natriuretic peptide. (2008) (6)
- GUIDELINE 2011 ACCF / AHA / HRS Focused Update on the Management of Patients With Atrial Fibrillation ( Updating the 2006 Guideline ) (2010) (6)
- 12 month report of a 3 arm multicenter comparison of Tacrolimus (TAC), MMF or TAC/Sirolimus(SRL) and steroids vs Cyclosporine microemulsion(CYA), MMF and steroids in de novo cardiac transplant recipients (2005) (6)
- Heart Failure and Its Management With β‐Blockade: Potential Applications of Once‐Daily Therapy (2007) (6)
- Preventable Deaths From Heart Disease and Stroke Among Racial and Ethnic Minorities in the United States. (2021) (6)
- Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction (2020) (6)
- New Blood Pressure-Lowering Targets-Finding Clarity. (2017) (6)
- Blacks and whites have a similar prevalence of reduced left ventricular ejection fraction in the general population: the Dallas Heart Study (DHS). (2008) (6)
- Cardiovascular Disease Disparities: The Gap Remains. (2018) (5)
- COVID-19 and Katrina: recalcitrant racial disparities (2020) (5)
- B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF (2012) (5)
- Temporal Trends in Risk Profiles Among Patients Hospitalized for Heart Failure. (2020) (5)
- 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19 (2022) (5)
- The editor's roundtable: role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease. (2011) (5)
- Buffer or Suffer: Redesigning Heart Failure Postdischarge Clinic Using Queuing Theory. (2018) (5)
- Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of IMPROVE HF (2009) (5)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. (2012) (5)
- B-type natriuretic peptides in management of acute decompensated heart failure. (2006) (5)
- Clinical trials of beta-blockers in heart failure: a class review. (2001) (5)
- Severe congestive heart failure. How successful are drug and transplant therapies? (1991) (5)
- Nesiritide is safe for CHF patients with renal insufficiency: retrospective results from the follow up serial infusions of nesiritide (FUSION) trial (2004) (5)
- The FDA and tobacco regulation. (2008) (5)
- Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT. (2019) (5)
- BiDil's impact (2005) (5)
- Acute Heart Failure: Searching for a New Evident Truth. (2017) (5)
- Race-based therapeutics (2007) (5)
- Natural History of Myocardial Late Gadolinium Enhancement Predicts Adverse Clinical Events in Heart Transplant Recipients. (2019) (5)
- United Network for Organ Sharing 2018 Heart Transplant Reallocation Policy: Aiming for Evidence-Based Policy. (2020) (5)
- Race/Ethnicity-Based Outcomes in Cardiovascular Medicine. (2017) (5)
- The Current Landscape of Atrial Fibrillation and Atrial Flutter Clinical Trials: A Report of 348 Studies Registered With ClinicalTrials.gov. (2017) (5)
- Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure. (2020) (5)
- Reporting Genetic Markers and the Social Determinants of Health in Clinical Cardiovascular Research-It Is Time to Recalibrate the Use of Race. (2020) (5)
- The Potential Impact of Expanding Cardiac Rehabilitation in Heart Failure. (2016) (5)
- Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations. (2020) (4)
- 2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee. (2020) (4)
- Treatment of ventricular dysrhythmias and sudden cardiac death: a guideline-based approach for patients with chronic left ventricular dysfunction. (2007) (4)
- Chronic Serial Infusion of Nesiritide Is Not Associated with Worsening Renal Function in Chronic Decompensated Heart Failure Patients with Renal Insufficiency: An Analysis from the FUSION-II Trial (2007) (4)
- Disparate quality of care for black and hispanic heart failure (HF) patients: A report from Get With the Guidelines-Heart Failure (GWTG-HF) (2007) (4)
- Advances in the management of acute and chronic decompensated heart failure. (2004) (4)
- Ventricular Assist Device Driveline Dressing Change Protocols: A Need for Standardization. A report from the SimVAD investigators. (2019) (4)
- Lipid treatment and survival after heart transplantation (1998) (4)
- Differential reflex control of forearm and calf resistance vessels by chemosensitive cardiac afferent activation. (1994) (4)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. (2013) (4)
- Cardiovascular disease outcomes: priorities today, priorities tomorrow for research and community health. (2012) (4)
- ACCF/AHA Practice Guideline (2013) (4)
- Special considerations for carvedilol use in heart failure. (2004) (4)
- Evaluating Readmission-Need for More Clarity on Methods-Reply. (2018) (4)
- The editor's roundtable: Acute decompensated heart failure. (2007) (4)
- Congestive heart failure. (1988) (4)
- Claims Data to Ascertain Clinical Events: Lost in Translation. (2017) (4)
- Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure (2020) (4)
- Initial Hospital, Patient, and Performance Measure Characteristics of the Organized Program To Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Program (2004) (4)
- Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes (2018) (4)
- Clinical characteristics and outcomes in patients admitted with heart failure with preserved systolic function: a report from the ADHERE™ database (2003) (4)
- PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized with Heart Failure. (2019) (4)
- TEMPORAL TRENDS IN CARDIAC REHABILITATION REFERRAL AMONG PATIENTS HOSPITALIZED WITH HEART FAILURE: ANALYSIS FROM AMERICAN HEART ASSOCIATION GET WITH THE GUIDELINES-HEART FAILURE REGISTRY (2015) (4)
- Blood Pressure and Glycemic Control Among Ambulatory US Adults With Heart Failure: National Health and Nutrition Examination Survey 2001 to 2018 (2022) (3)
- Improved outcomes in patients awaiting heart transplantation: making the case that status 2 patients should not undergo transplantation (2002) (3)
- Cardiac Transplantation Outcomes in Patients with Amyloid Cardiomyopathy (2019) (3)
- Data Sharing-The Time Has (Not Yet?) Come. (2018) (3)
- An individualized protocol is more accurate than a standard protocol for assessing exercise capacity after heart transplantation. (1996) (3)
- Relationship between Hospital 30-Day Mortality Rates for Heart Failure and Patterns of Early Inpatient Comfort Care (2018) (3)
- 2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee. (2020) (3)
- The COVID-19 Vaccine and the Black Community: Addressing the Justified Questions (2021) (3)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. (2013) (3)
- The editor's roundtable: Cardiac resynchronization therapy. (2007) (3)
- Why Continuity of STEM-Medicine Participation Matters: Exploring a Culture of Transformation and the Optimization of College Socialization (2022) (3)
- Association Between Neighborhood-Level Poverty and Incident Atrial Fibrillation: a Retrospective Cohort Study (2021) (3)
- SAFETY AND EFFICACY OF OUT PATIENT NESIRITIDE IN PATIENTS WITH ADVANCED HEART FAILURE. RESULTS OF THE SERIAL INFUSION OF NESIRITIDE (FUSIONII) TRIAL (2008) (3)
- 125: Treatment of HLA sensitized pre-transplant patients with mechanical support is effective for PRA reduction (2007) (3)
- Is the Affordable Care Act Medicaid Expansion Associated with Receipt of Heart Failure Guideline-Directed Medical Therapy By Race and Ethnicity? (2021) (3)
- Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines‐Heart Failure Registry (2022) (3)
- Is the Left Ventricular Ejection Fraction Measurement Still Preeminent?-New Measures to Quantify Subclinical Systolic Dysfunction. (2021) (3)
- The Heart Failure Society of America in 2020: a vision for the future. (2012) (3)
- The New Hypertension Guidelines: Compelling Population Benefit, Manageable Risk, and Time to Implement. (2018) (3)
- Risk-Based Intensive Blood Pressure Lowering and Prevention of Heart Failure: A SPRINT Post Hoc Analysis (2021) (3)
- Cardiac resynchronization therapy for heart failure: has the time come? (2009) (3)
- Disparate care for acute myocardial infarction: moving beyond description and targeting interventions. (2014) (3)
- Reimagining educational equity through strategic alliance partnerships in response to the USA STEM-M diversity gap. (2021) (3)
- Identifying Treatments for Stage C2 Heart Failure. (2021) (3)
- Improving Outcomes in the Post‐Myocardial Infarction Setting (2004) (3)
- Fibroblast Growth Factor-23 and Subclinical Markers of Cardiac Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. (2021) (3)
- Get with the guidelines steering committee and hospitals, sex and racial differences in the use of implantable cardioverter & defibrillators among patients hospitalized with heart failure (2007) (3)
- Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure-There Is No Time for Delay. (2021) (3)
- Heart-Kidney Transplantation in a Transgender Woman (2022) (3)
- Profile of Patients Hospitalized for Heart Failure Who Leave Against Medical Advice. (2021) (2)
- Health‐Related Quality of Life in Older Patients With Advanced Heart Failure: Findings From the SUSTAIN‐IT Study (2022) (2)
- Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure". (2018) (2)
- High-Intensity Statins for Secondary Prevention. (2017) (2)
- An Expanded Heart Failure Indication for Sacubitril/Valsartan: Evolving the Evidence Bar. (2021) (2)
- ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults (2009) (2)
- Reply: To PMID 23273288. (2013) (2)
- Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry. (2022) (2)
- Malignancy and death from malignancy after heart transplantation, a multicenter time related risk analysis (2002) (2)
- EQUITABLE IMPROVEMENT FOR WOMEN AND MEN IN THE USE OF GUIDELINE-RECOMMENDED THERAPIES FOR HEART FAILURE: FINDINGS FROM IMPROVE HF (2010) (2)
- Affirming and Nurturing Students’ Cultural Wealth to Enhance Self-efficacy: Examination of Urban High School Students’ Lived Experiences in a STEM-Medicine Pipeline Program (2022) (2)
- The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation. (2011) (2)
- Cardiac Allograft Vasculopathy Post Heart Transplantation: MRI Structural Parameters in Patients Trending towards Restrictive Physiology (2019) (2)
- Explanation for the Corrections for the Study of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019. (2020) (2)
- Cutaneous malignancies after cardiac transplantation-risk factors and effect on late survival (2005) (2)
- Equity and the JAMA Network. (2021) (2)
- Treatment of heart failure in African Americans: executive summary. (2010) (2)
- Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients with HFrEF: Results from the CONNECT-HF Trial. (2022) (2)
- Abstract 2947: Evolving Patterns of Use of Aldosterone Inhibition in Chronic Heart Failure; A Report from Get with the Guidelines HF (2008) (2)
- Equity and the JAMA Network. (2021) (2)
- Sacubitril/valsartan Initiation and Adherence Patterns Following Hospitalization for Heart Failure (2020) (2)
- Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States. (2023) (2)
- Clinical Effectiveness of CRT and ICD Therapy in Men and Women with Heart Failure: Findings from IMPROVE HF (2013) (2)
- Isosorbide Dinitrate and Hydralazine as Therapy for African Americans with Heart Failure; a Failed Paradigm? (2009) (2)
- Better outcomes in heart failure in African Americans despite negative risk factors; a report from the ADHERE™ database (2003) (2)
- Patients With ST-Elevation Myocardial Infarction : 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of (2012) (2)
- Evaluating Biventricular Myocardial Velocity and Interventricular Dyssynchrony in Adult Patients During the First Year After Heart Transplantation. (2020) (2)
- Influence of the American Heart Association's Get With The Guidelines (GWTG) Program on the Quality of Care for Patients Hospitalized with Heart Failure (2006) (2)
- Overview of B-type natriuretic peptide as a blood test. Roundtable discussion. (2006) (2)
- Development and Validation of a Long-Term Incident Heart Failure Risk Model (2021) (2)
- Abstract 2382: The Influence of Electronic Health Records on Quality of Care for Heart Failure (2008) (2)
- Anticipating a New Era in Heart Transplantation. (2020) (2)
- Impediments to Implementing Guideline-Directed Medical Therapies. (2019) (2)
- Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State. (2020) (2)
- The editor's roundtable: medical management of atrial fibrillation. (2012) (2)
- Association of post‐vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high‐risk cardiovascular disease: the INVESTED trial (2022) (2)
- Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction (2021) (2)
- A moment of reflection on the past and future of the Association of Black Cardiologists: the history, legacy, and relevance of a socially conscious organization dedicated to cardiovascular health equity. (2015) (2)
- Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina Lente. (2016) (2)
- Tipping the scale toward a more accurate and equitable assessment of heart failure with reduced ejection fraction pharmacotherapy eligibility: a call to incorporate cystatin C in estimating glomerular filtration rate (2022) (2)
- The Association of Smoking History and Outcomes following Left Ventricular Assist Device Implantation (2018) (2)
- AHA Presidential Advisory Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond A Presidential Advisory From the American Heart Association (2011) (2)
- Immediate vs delayed diagnosis of heart failure: is there a difference in outcomes? results of a harris interactive® Patient Survey (2004) (2)
- Lack of Improvement in 30-day Readmission Rates for Patients Hospitalized with Heart Failure: Data from Get With The Guidelines-Heart Failure Registry (2015) (2)
- Results of the Extension to A-HeFT [X-A-HeFT] Support the Continued Safety and Tolerability of Fixed-Dose Isosorbide Dinitrate/Hydralazine (ISDN/HYD) (2006) (2)
- Cardiology patient page. Online program aids heart patients and their doctors. (2002) (2)
- Force on Practice Guidelines, International Society for Heart and Lung American College of Cardiology Foundation/American Heart Association Task Diagnosis and Management of Heart Failure in Adults 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the (2009) (2)
- A Patient-Centric Conceptual Framework for Health-related Quality of Life in Mechanical Circulatory Support (2014) (2)
- To VAD or Not to VAD: A Case of Durable Left Ventricular Assist Device Implantation in a COVID-19 Patient (2021) (2)
- Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. (2012) (2)
- Stroke prevention in heart failure and sinus rhythm: where do we go from here? (2016) (2)
- Abstract 14678: Prevalence Of Sglt2 Inhibitor And Glp-1 Receptor Agonist Prescriptions In Patients With Comorbid Diabetes And Cardiovascular Disease In An Integrated Academic Health System (2020) (2)
- Donor and Recipient Characteristics in Heart Transplantation Are Associated with Altered Myocardial Tissue Structure and Cardiac Function. (2019) (2)
- Equity and the JAMA Network. (2021) (2)
- Documentation of QRS Duration and NYHA Class in HF Patients after a Performance Improvement Initiative: IMPROVE HF (2010) (2)
- Abstract 3280: Heart Failure Quality of Care in the Outpatient Cardiology Practice Setting: A Report from IMPROVE HF (2007) (2)
- Abstract 24: Amyloidogenic V122I Transthyretin Variant is Associated With Progression of Adverse Cardiac Mechanics in Middle-aged African American Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (2020) (1)
- Pharmacist Education at Discharge Correlates with Reduced 30-Day Readmissions in Heart Failure Patients (2017) (1)
- Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Program". (2017) (1)
- The quality of care for patients hospitalized with ischemic verses nonischemic heart failure in the American Heart Association's Get With the Guidelines (GWTG-HF) Program (2007) (1)
- Equity and the JAMA Network. (2021) (1)
- ANTI-HYPERGLYCEMIC MEDICATION USE AMONG MEDICARE BENEFICIARIES WITH HEART FAILURE, DIABETES, AND CHRONIC KIDNEY DISEASE (2015) (1)
- MYOCARDIAL T2-MAPPING PREDICTS ADVERSE CARDIAC EVENTS IN HEART TRANSPLANTATION PATIENTS (2020) (1)
- President's page: the American College of Cardiology and the American Heart Association: a strong, synergistic partnership. (2010) (1)
- HEART FAILURE RISK DISTRIBUTION AND TRENDS IN THE UNITED STATES POPULATION FROM 1999-2014: RESULTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (2019) (1)
- Equity and the JAMA Network. (2021) (1)
- CHRONIC STRUCTURAL EFFECTS OF BIOPSY PROVEN 2R REJECTION IN HEART TRANSPLANT PATIENTS (2020) (1)
- Association of cigarette smoking and adverse events in left ventricular assist device patients (2020) (1)
- Abstract 248: IMPLEMENT-HF: An Initiative To Improve Guideline Adherence Across The Continuum (2022) (1)
- Patient‐reported outcome measures and patient engagement in heart failure clinical trials: multi‐stakeholder perspectives (2023) (1)
- Special clinical considerations of beta-blocker treatment. (2002) (1)
- Is Heart Failure Inherited?: Beyond the Cardiomyopathies, Genetics Do Matter. (2018) (1)
- Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT): Sex Differences for Non-Enrollment. (2020) (1)
- Characteristics of patients with stage D heart failure: Initial report from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE®-LM) (2005) (1)
- Primary Prevention of Heart Failure (2004) (1)
- Use of Nesiritide in the Management Algorithm of Acute Decompensated Heart Failure (2008) (1)
- Heart Disease in Varied Populations (2012) (1)
- Mechanisms, and Future Directions Hydralazine and Isosorbide Dinitrate in Heart Failure : Historical Perspective, (2012) (1)
- Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study (2021) (1)
- Procedural Volumes, Outcomes, and Quality in Hypertrophic Cardiomyopathy. (2016) (1)
- Integrative Supports, Resources, and Opportunities—Exploring and Expanding Urban High School Students’ Science Identity: A Longitudinal Qualitative Study (2022) (1)
- The ICD and Shared Decision Making: Nothing Is Ever Easy. (2017) (1)
- Treatment of heart failure in African Americans: clinical update. (2002) (1)
- Abstract 17399: Phenomapping: Hierarchical Cluster Analysis of Phenotypic Data for the Classification of Heart Failure and Preserved Ejection Fraction (2012) (1)
- BiDil's impact [1] (multiple letters) (2005) (1)
- Would Risk-Stratified Intensive Blood Pressure Lowering Prevent Heart Failure More Effectively? (2019) (1)
- Abstract 19250: Importance of Considering Competing Risks in Patients With a Left Ventricular Assist Device (LVAD) (2016) (1)
- Is nesiritide safe and effective for acute heart failure (2005) (1)
- Who Is at Risk for Heart Failure? (2022) (1)
- Abstract 152: Enterprise Data Warehouse-Supported Early Identification of Acute Decompensated Heart Failure Admissions for Efficient and Multidisciplinary Transitional Care Team Interventions (2016) (1)
- Change in Health-Related Quality of Life from Before to Early after Surgery: Findings from the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) Study (2019) (1)
- The Journey Toward Health Equity: Are We Nearing an Abyss or Ascending a Peak? (2021) (1)
- Do Hospitals That Provide Heart Failure Patient Education Prior To Discharge Also Promote Continuity of Care? A Report from OPTIMIZE-HF (2006) (1)
- Abstract 3993: Quality of Care for Heart Failure Patients with Concomitant Kidney Disease in the American Heart Association’s Get With The Guidelines Heart Failure (GWTG-HF) Program (2006) (1)
- Does Guideline-Directed Medical Therapy for Heart Failure Offer Benefits After LVAD Placement?-A Call for a Randomized Clinical Trial. (2019) (1)
- Prognostic value of MRI T2 quantification in heart transplant patients: a 5-year outcome study (2016) (1)
- FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART (2009) (1)
- Transformation of cardiovascular health: presidential address at the American Heart Association 2009 scientific sessions. (2010) (1)
- Cancer therapy and the heart; the necessity to calibrate risk (2020) (1)
- Abstract 16562: Association of County-Level Social Vulnerability Index and Cardiovascular Disease in the United States, 1999-2018 (2020) (1)
- Change the Name of the Blalock-Taussig Shunt to Blalock-Thomas-Taussig Shunt. (2021) (1)
- Trends in Place of Cardiovascular Deaths Related to Heart Failure in the United States from 2003-2017 (2019) (1)
- Self-Reported Physical Health with a Left Ventricular Assist Device: Findings from the Mechanical Circulatory Support Measures of Adjustment and Quality of Life (MCS A-QOL) Study (2019) (1)
- CLINICAL PROFILES, MEDICAL THERAPIES, AND OUTCOMES AMONG PATIENTS HOSPITALIZED FOR HF ACROSS THE SPECTRUM OF KIDNEY FUNCTION: THE GWTG-HF REGISTRY (2021) (1)
- Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy (2022) (1)
- Pharmacist-Led Transition of Care Interventions Identify and Reduce Medication Errors in Heart Failure Patients Post-Discharge (2016) (1)
- The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care About Cost and Value? (2020) (1)
- The TREAT Trial-Moving ST-Elevation Myocardial Infarction Care Forward, With More to Do. (2018) (1)
- Heart Failure With Preserved Ejection Fraction and Obesity (2020) (1)
- Equity and the JAMA Network. (2021) (1)
- Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure (1)
- Abstract P449: Associations of Unhealthy Food and Physical Activity Environments With Adverse Cardiac Function: The Coronary Artery Risk Development in Young Adults (Cardia) Study (2020) (1)
- Equity and the JAMA Network. (2021) (1)
- To be, or not to be BAME, in the time of COVID-19: does it matter? (2021) (1)
- Nonprofit Advocacy at the American Heart Association: Creating a Visionary Way Forward at Our 40th Anniversary: An American Heart Association Policy Statement (2021) (1)
- Impact of BMI on Heart Failure by Race/Ethnicity from Get With The Guidelines-Heart Failure Registry (2018) (1)
- Abstract 2740: Influence of the American Heart Association's Get with the Guidelines Heart Failure (GWTG-HF) Program on Emerging Performance Measures for Patients Hospitalized with Heart Failure (2006) (1)
- Abstract 384: Affordable Care Act Medicaid Expansion Then and Now: Racial/Ethnic Differences in Receipt of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations (2020) (1)
- Management of heart failure with renal artery ischemia. (2011) (1)
- Abstract 12794: Hospital Length of Stay and Readmissions Post Heart Failure Hospitalization in the EVEREST Trial (2014) (1)
- Weekend Hospital Admission for Heart Failure: Influence on Quality of Care, Length of Stay, and In-Hospital Mortality (2008) (1)
- Influence of Race on Improvements in Use of Guideline Recommended Heart Failure Therapies: Findings from IMPROVE HF (2010) (1)
- What Happens to Right Ventricular Strain and Function Following Tricuspid Valve Repair in Patients Undergoing Implantation of a Left Ventricular Assist Device? (2019) (0)
- TISSUE PHASE MAPPING ANALYSIS IN PATIENTS WITH INCREASED CARDIOPULMONARY PRESSURES AFTER HEART TRANSPLANTATION (2020) (0)
- The Association between Beta-Blocker and Renin Angiotensin System Inhibitor Use After HFrEF Hospitalization and Outcomes in Older Patients. (2022) (0)
- Treatment of Hypertrophic Cardiomyopathy (2011) (0)
- Influence of etiology on the survival advantage of women with advanced heart failure (2003) (0)
- Abstract 9232: Admission Heart Rate and In-Hospital Outcomes in Patients Hospitalized for Heart Failure (2012) (0)
- Abstract 16757: Early Ambulation Among Hospitalized Heart Failure Patients is Associated With Decreased Length of Stay and Higher Rates of Discharge to Home (2016) (0)
- Process Improvement and Adopting the 2015 American Heart Association Resuscitation Guidelines. (2016) (0)
- TEMPORAL TRENDS IN EARLY FOLLOW-UP AFTER HOSPITALIZATION FOR HEART FAILURE: DATA FROM GET WITH THE GUIDELINES-HEART FAILURE (2014) (0)
- Abstract 15734: Intersection of Atrial Fibrillation and Heart Failure With Mildly Reduced and Preserved Ejection Fraction in >400,000 Participants in the Get With the Guidelines® Heart Failure Registry (2022) (0)
- Race Based Inequity in the Modern Era of Heart Transplantation (2021) (0)
- Soluble CD30 in heart transplant recipients (2005) (0)
- 32 – Heart Failure (2018) (0)
- Safety vs Efficacy of Lowering Blood Pressure-Reply. (2017) (0)
- Letter by Ferdinand et al regarding article, "Does black ethnicity influence the development of stent thrombosis in the drug-eluting stent era?". (2011) (0)
- Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support ( SUSTAIN-IT ): Baseline Findings (2018) (0)
- The Role of Right Ventricular Strain in Women and Men Following Left Ventricular Assist Device Implantation (2019) (0)
- Race, Ethnicity, & Social Determinants in COVID-19: An Expert Panel Discussion (2020) (0)
- Hyponatremia Is a Powerful Predictor of Poor Prognosis in Left Ventricular Assist Device Patients (2022) (0)
- Abstract 22: Affordable Care Act Medicaid Expansion Then and Now: Racial/Ethnic Differences in Receipt of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations (2020) (0)
- TEMPORAL TRENDS IN SEVERITY IN CLINICAL RISK PROFILES AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE (2020) (0)
- Novel County-Level Non-Communicable Disease Risk (NCDR) Groups are Associated with Contemporary Cardiovascular Mortality Related to Heart Failure in the United States, 2016-18 (2020) (0)
- Association of Readmission Penalty Amount with Subsequent 30-Day Risk Standardized Readmission and Mortality Rates Among Patients Hospitalized with Heart Failure: An Analysis of Get With The Guidelines - Heart Failure Participating Centers. (2021) (0)
- Does Hospital Length of Stay for Heart Failure Influence Compliance with Performance Measures? (2007) (0)
- 357: Does basiliximab decrease acute rejection and improve renal function in cardiac transplant recipients at mid-term follow-up (2006) (0)
- Differences in Health-Related Quality of Life by Socio-Demographic Characteristics: Findings from the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) Study (2019) (0)
- G-PROTEIN RECEPTOR KINASE 5 POLYMORPHISMS AND OUTCOMES IN THE AFRICAN AMERICAN HEART FAILURE TRIAL: RESULTS FROM THE GENETIC RISK ASSESSMENT OF HEART FAILURE IN AFRICAN-AMERICANS SUB-STUDY (2017) (0)
- Title Health Literacy and the Patient With Heart Failure-Implications for Patient Care and Research : A Consensus Statement of the Heart Failure Society of America Permalink (2009) (0)
- Abstract 10413: Clinical Outcomes with Metformin and Sulfonylurea Initiation Among Patients with Heart Failure and Diabetes: From Get with the Guidelines-Heart Failure (2021) (0)
- Race Bias in Transcatheter Aortic Valve Replacement: Are We Sure? (2021) (0)
- Blacks as Compared to Whites Do Not Have an Increased Prevalence of Reduced Left Ventricular Ejection Fraction in the General Population (2006) (0)
- Abstract 036: Derivation and Validation of a Novel Risk Equation for 10-year Risk of Incident Heart Failure in the General US Population (2018) (0)
- Author Relationships With Industry: Policies and Procedures for Authors and Editors of JAMA Cardiology. (2017) (0)
- Potential Mortality ReductionWith Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure (2016) (0)
- MYCOPHENOLATE MOFETIL DEMONSTRATES NO ADVANTAGE OVER AZATHIOPRINE ON STEROID WITHDRAWAL IN CARDIAC TRANSPLANT RECIPIENTS: A SINGLE CENTER EXPERIENCE (1999) (0)
- Abstract P370: Healthcare utilization in older adults with chronic heart failure and elevated depressive symptoms: Cardiovascular Health Study (2014) (0)
- Managing Cardiovascular Disease in African Americans: Emerging Strategies for Optimizing Care (2004) (0)
- Wednesday, May 16, 7:00 PM to 9:00 PM From HTN to HF: Vasculature & Myocardial Mechanisms: The Impact on Clinical Practice*: Hypertension and left ventricular function: Case studies (2001) (0)
- Reducing Disparities in Cardiovascular Health in African Americans through Integrated Cardiovascular Sleep Care in Outpatient Setting (2022) (0)
- Abstract 807: Incremental Value of Clinical Data Beyond Claims to Predict 30-Day Outcomes Following Heart Failure Admission: Results From the AHA's Get With the Guidelines-Heart Failure Registry (2009) (0)
- Are Patient Age and Gender Associated with Delivery of Recommended HF Therapies (2007) (0)
- Equity and the JAMA Network. (2021) (0)
- Heart Failure (2020) (0)
- Abstract 15422: Distribution of 10- and 30-year Predicted Risks for Heart Failure in the United States: NHANES 2015 to 2018 (2020) (0)
- Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry. (2023) (0)
- Abstract 10632: Variation in the Association Between Beta Blocker and/or Rasi Use After Discharge and Outcomes in Hfref by Age (2021) (0)
- CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF HOSPITALIZED HEART FAILURE PATIENTS STRATIFIED BY ETIOLOGIES OF NON-ISCHEMIC CARDIOMYOPATHY (2014) (0)
- Positively Double Jeopardy - Dual Organ Transplantation in an HIV+ Patient (2020) (0)
- Title Social determinants of risk and outcomes for cardiovascular disease : A scientific statement from the American Heart Association Permalink (0)
- Home-Time as a Novel Post-Discharge Outcome for Patients Hospitalized with Heart Failure (2019) (0)
- Abstract 16697: Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From the American Heart Association’s Get With the Guidelines-Heart Failure Registry (2016) (0)
- Influence of Atrial Fibrillation on the Use of CRT and ICD Therapy in Heart Failure: Findings from IMPROVE HF (2009) (0)
- Editorial Board (2011) (0)
- The editor's roundtable: anemia and cardiovascular disease. (2011) (0)
- Physical Function and Social Interaction after Mechanical Circulatory Support: Patient Perspectives (2013) (0)
- Abstract 12031: Initiation, Continuation, or Withdrawal of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction (2016) (0)
- Therapeutic Strategies for Heart Failure (2018) (0)
- I Have High Blood Pressure: What Do I Need to Know? (2017) (0)
- Abstract 15374: Interaction of G-Protein Beta 3 Subunit (GNB3) and G-Protein Receptor Kinase 5 (GRK5) Genotypes Impacts Heart Failure Outcomes in African Americans (2017) (0)
- Editorial Board (2010) (0)
- Use and Predictors of Heart Failure Disease Management Referral in Patients Hospitalized With Heart Failure: Insights from the American Heart Association – Get with the Guidelines Program (2010) (0)
- Cardiac Resynchronization Therapy for Heart Failure (2009) (0)
- Ventricular Assist Device Driveline Dressing Protocols: A Need for Standardization (2019) (0)
- beta-Blocker therapy for congestive heart failure: clinical considerations. (2005) (0)
- The Association of Donor Cause of Death with Outcomes Post-Heart Transplant (2019) (0)
- Editorial board (1993) (0)
- Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease. (2022) (0)
- Management of heart failure with renal artery ischemia. (2008) (0)
- Anti-MICA allo-antibodies in sera from heart allograft recipients at risk of transplant-associated coronary artery disease (2005) (0)
- 5 6 Developed in Collaboration With the American Academy of Family Physicians, American College 7 of Chest Physicians, Heart Rhythm Society and International Society for Heart and Lung (2013) (0)
- Iconographies supplémentaires de l'article : The prevention of heart failure in minority communities and discrepancies in health care delivery systems (2011) (0)
- Best clinical trials reported in 2010. (2011) (0)
- Abstract 12458: Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease (2016) (0)
- The Editor's Roundtable: Health reform and its implications for cardiovascular medicine. (2010) (0)
- Metabolic correlates of peripheral blood flow in congestive heart failure (1988) (0)
- Late Gadolinium Enhancement Predicts Adverse Clinical Events in Heart Transplant Patients (2019) (0)
- Predictors of Length of Stay in Patients Hospitalized with Heart Failure: A Report from OPTIMIZE-HF (2007) (0)
- Racial Disparities in Blood Pressure Treatment and Control in US Heart Failure Patients: National Health and Nutrition Examination Surveys 1999-2016 (2019) (0)
- Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure (2022) (0)
- In response to Nagarajan's letter to the editor “Improvement in ejection fraction—but do not forget the basics, the medications” (2012) (0)
- 52: Desensitization Therapy Is Associated with Improved Survival to Transplant in Sensitized Patients Bridged with a Left Ventricular Assist Device (2009) (0)
- Serial outpatient infusions of nesiritide over 12 Weeks decrease hospitalization and mortality in chronic decompensated heart failure compared to “standard” therapy: a subgroup analysis of the fusion trial (2004) (0)
- Process Improvement in Heart Failure (2020) (0)
- Abstract P301: Are Variations in Delivery of Guideline Recommended Therapies by Cardiology Practices Reduced After Implementation of a Performance Improvement Initiative? Findings From IMPROVE HF (2011) (0)
- Abstract 215: Leveraging Electronic Health Record Documentation for Failure Mode and Effects Analysis Team Identification on an Inpatient Cardiology Unit (2016) (0)
- Congestion at rest ? ( Warm ) No Yes Low perfusion No Warm and Dry Warm and Wet at rest ? ( Cold ) Yes Cold and Dry Cold and Wet (2012) (0)
- POST-DISCHARGE MORTALITY AND READMISSION IN HEART FAILURE PATIENTS WITH PRESERVED, BORDERLINE, AND REDUCED LEFT VENTRICULAR EJECTION FRACTION (2014) (0)
- Geographic Variation in Trends and Disparities in Cardiovascular Mortality Related to Heart Failure in the United States, 2000-2017 (2019) (0)
- Cardiac Transplantation With Increased-risk Donors: Trends And Clinical Outcomes (2023) (0)
- 414 Clinical differences between high and low mortality risk stratified patients hospitalized with acutely decompensated heart failure: adhere® Registry Data (2004) (0)
- Heart Failure Management Under Pressure. (2019) (0)
- Hyponatremia is Associated with Poor Prognosis in Left Ventricular Assist Device Patients (2018) (0)
- Race-Based Analyses in Heart Failure Clinical Trials: What Makes Them Informative? (2023) (0)
- ASSOCIATION BETWEEN ASSIGNMENT TO AN ACCOUNTABLE CARE ORGANIZATION AND QUALITY OF CARE AND OUTCOMES AMONG MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2019) (0)
- Introduction: heart failure in African Americans. (2004) (0)
- Abstract 3003: Greater Improvement in Heart Failure Care Quality With a Performance Improvement Initiative is Largely Independent of Patient and Practice Characteristics (2009) (0)
- Equity and the JAMA Network. (2021) (0)
- Abstract 077: Hospitalized Heart Failure Epidemiology: Active Surveillance to Enhance Inpatient Cardiology Consultation Rates (2017) (0)
- Hospitalized Heart Failure Incidence is Significantly Underestimated by Diagnosis-Related Group Codes (2016) (0)
- In reply [7] (2007) (0)
- Treatment: special conditions: co-existing heart disease: atrial fibrillation. (2015) (0)
- HEART FAILURE CARE TRANSITIONS: QUEUING THEORY-BASED COST-EFFECTIVENESS ANALYSIS OF OUTPATIENT CLINIC CAPACITY SIZING (2017) (0)
- Coronary Artery Calcium as a Predictor of Incident Heart Failure with Preserved Ejection Fraction: Results from the Multi-Ethnic Study of Atherosclerosis (MESA) (2015) (0)
- HFrEF pharmacological treatment: hydralazine and isosorbide dinitrate (2018) (0)
- MYOCARDIAL DYNAMICS AND RIGHT HEART PRESSURES CORRELATION AFTER HEART TRANSPLANTATION (2020) (0)
- Abstract 15007: Association Of Dual Eligibility For Medicare And Medicaid With Heart Failure Quality And Outcomes Among Gwtg-hf Hospitals (2020) (0)
- CorrespondenceLetter to the EditorReply (2006) (0)
- Impact of nesiritide infusion on acute decompensated heart failure in an urban hospital emergency department (2004) (0)
- Insights from a Systematic Examination of a Novel Heart Failure Risk Prediction Tool: The Pooled Cohort Equations to Prevent Heart Failure (2019) (0)
- Abstract 17325: Association of Risk Adjusted 30 Day Heart Failure Readmission Rates Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes: Findings From the American Heart Association Get With the Guidelines-Heart Failure Program (2016) (0)
- Abstract 377: Characteristics, Care, and Outcomes of Asian American Heart Failure Patients: Findings from the American Heart Association Get With The Guidelines-Heart Failure Program (2014) (0)
- Variation in HF Quality of Care among US Outpatient Practices: Analysis of 131 Cardiology Practices in IMPROVE HF (2007) (0)
- Nurturing Diverse Generations of the Medical Workforce for Success With Authenticity: An Association of Black Cardiologists’ Roundtable (2023) (0)
- Omitted Conflict of Interest Disclosures. (2019) (0)
- Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry. (2023) (0)
- Validation of Heart Failure Risk Equations in a Large, Contemporary Electronic Health Record Cohort (2019) (0)
- Abstract 16571: The Potential Impact of Expanding Cardiac Rehabilitation Coverage in Heart Failure: Insights From Get With the Guidelines Heart Failure (2015) (0)
- Propensity Score-Matched Comparison of Right Ventricular Strain in Women and Men Before and After Left Ventricular Assist Device Implantation (2022) (0)
- Abstract 13701: Change in Caregiver Burden From Before to 1 Year After Surgery: Findings From the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support ( Sustain-IT ) Study (2020) (0)
- Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association. (2022) (0)
- A Simulation-Based Mastery Learning Approach to Ventricular Assist Device Self-Management: The SimVAD Study (2018) (0)
- APPLICABILITY OF THE GALACTIC-HF TRIAL AND OMECAMTIV MECARBIL TO PATIENTS HOSPITALIZED FOR HEART FAILURE IN THE UNITED STATES: FROM THE GWTG-HF REGISTRY (2023) (0)
- Distribution of 10- and 30-Year Predicted Risks for Heart Failure in the US Population: National Health and Nutrition Examination Surveys 2015 to 2018. (2022) (0)
- Increasing Burden of Heart Failure in Black Adults in the US: 1999-2016 (2019) (0)
- Abstract 161: Heart Failure Care Transitions: A Queuing Theory Approach to Match Variable Hospital Discharge Rate With Outpatient Clinic Capacity (2016) (0)
- Abstract 11748: Mechanical Circulatory Supportmeasures of Adjustment and Quality of Life: Findings on Self-Reported Mental Health (2018) (0)
- Significant Gaps in Adherence to Guideline Recommended Adjunctive Heart Failure Therapies among Outpatient Cardiology Practices: Findings from IMPROVE HF (2008) (0)
- Both Patient and Caregiver Factors are Related to Patient Health-Related Quality of Life before Surgery. (2020) (0)
- The impact of gender on prognosis in patients with advanced heart failure (2002) (0)
- Caregiving Affects the Quality of Life of Patients and their Caregivers after Mechanical Circulatory Support (2015) (0)
- Experts Convene to Discuss Latest ACCF/AHA Heart Failure Guidelines (2014) (0)
- Abstract 19573: Factors Associated With Improvement in Ejection Fraction in Heart Failure Patients Following Implementation of a Practice-Based Performance Intervention: Findings From IMPROVE HF (2010) (0)
- Sustaining Quality of Life of the Aged: Transplant or Mechanical Support: Baseline Cognitive Dysfunction (2018) (0)
- Commentary - The Treatment of Heart Failure in African Americans (2020) (0)
- FUSION II: No Advantage for Serial Nesiritide Infusions (2007) (0)
- Abstract 21161: Use of an Open Access Multi-Sponsor Data Sharing Platform in Cardiology (2017) (0)
- Resident Physician Wellness Postpandemic: How Does Healing Occur? (2022) (0)
- Assessment of U.S. heart transplantation equity as a function of race: Observational analyses of the OPTN database (2022) (0)
- Potential Interaction of Nesiritide with Clinical Variables (2010) (0)
- Risk Scores From PARISRegistry (0)
- Heart Failure in African Americans and Hispanic Americans: A Persistent and Disproportionate Burden in Underrepresented Minorities (2021) (0)
- Abstract 214: Strict versus Lenient versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure: Findings From the Get With the Guidelines - Heart Failure Program (2018) (0)
- Summary: Cardiovascular disease in African Americans. (2004) (0)
- Abstract 219: Health System Integration: Heart Failure Processes of Care Vary Significantly in a Large Academic Network (2019) (0)
- I LETTERS TO THE EDITOR Chest Discomfort, Cocaine, and Tobacco (1995) (0)
- 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. (2023) (0)
- Abstract 136: Complexity and Collaboration in Discharge Planning for Inpatient Cardiology (2016) (0)
- Response to Letter Regarding Article, "Temporal Trends and Variation in Early Scheduled Follow-up After a Hospitalization for Heart Failure: Findings from Get With The Guidelines-Heart Failure. (2016) (0)
- New Biomarkers in Heart Failure; the Bar is High. (2022) (0)
- Clinical Decompensation in Stable Patients With Chronic Heart Failure Utility of Impedance Cardiography for the Identification of Short-Term Risk of (2006) (0)
- Social Health with a Left Ventricular Assist Device is Similar to the General Population, Regardless of Time Since Implant (2019) (0)
- Abstract 13558: Caregiver Anxiety Reduced From Baseline to 12 Months After Surgery: Findings From the Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Circulatory Support ( Sustain-it ) Study (2020) (0)
- Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors among Medicare Beneficiaries Hospitalized for Heart Failure. (2021) (0)
- Influence of Advance Practice Nurse and Dedicated Heart Failure Clinics on Delivery of Recommended Therapies in Outpatient Cardiology Practices: IMPROVE HF Findings (2008) (0)
- Response to Letter Regarding Article, “Hydralazine and Isosorbide Dinitrate in Heart Failure: Historical Perspectives, Mechanisms, and Future Directions” (2011) (0)
- Incorporating Cultural Competence and Cultural Humility in Cardiovascular Clinical Trials to Increase Diversity Among Participants. (2022) (0)
- Equity and the JAMA Network. (2021) (0)
- The Critical Need for Process Improvement in Heart Failure (2020) (0)
- Late survival after heart transplantation: are we getting better at long-term management? (2004) (0)
- Heart Failure Data Challenge: Democratizing Data, Modernizing Methods, and Interpreting Inequity. (2022) (0)
- LIMITED TESTING FOR CORONARY ARTERY DISEASE IN PATIENTS WITH NEW-ONSET HEART FAILURE: FINDINGS FROM GET WITH THE GUIDELINES - HEART FAILURE (2020) (0)
- Reply: Why to Replace an ACE or ARB With an ARB/Neprilysin Inhibitor? (2016) (0)
- Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure (2023) (0)
- Abstract MP28: Heart Rate At Hospital Discharge Is Associated With Adverse Long Term Outcomes In Patients With Heart Failure (2014) (0)
- Antibodies against donor HLA antigens after heart transplantation (2004) (0)
- Outpatient Documentation of NYHA Functional Class and/or Activity Level in HF Patients: A Report from IMPROVE HF (2007) (0)
- Abstract 025: Association of Dietary Patterns and Lifetime Risk of Heart Failure: The Cardiovascular Disease Lifetime Risk Pooling Project (2019) (0)
- Reliability of Heart Failure Patient Care: Initial Results from the American Heart Association's Get With The Guidelines (GWTG) Heart Failure Program (2006) (0)
- What do heart failure patients know about congestive heart failure? results of a harris interactive® Patient Survey (2004) (0)
- Abstract 278: Trends in Prescribing Patterns for Patients Hospitalized With Heart Failure With Preserved Ejection Fraction Before and After Clinical Trial Presentation (2018) (0)
- Abstract 12: Heart Failure Medications Prescribed at Discharge for Patients With Left Ventricular Assist Devices (2016) (0)
- Diabetes is Associated with Worse In-Hospital and 30-Day Post-Discharge Morbidity in Patients with Heart Failure with Preserved Ejection Fraction: Findings from the Get With The Guidelines Heart Failure Registry (2018) (0)
- Patient Satisfaction Remains High from 3 - 6 Months After Lvad Implant: Findings from Mcs A-qol (2020) (0)
- Impact of Depression on Survival, Rejection, and Hospitalization Rates after Heart Transplantation (2012) (0)
- Left Ventricular Assist Devices in Patients with Transposition of the Great Arteries: Survival and Adverse Events (2020) (0)
- A Policy Recommendation From the American Heart Association American Heart Association and Nonprofit Advocacy: Past, Present, and Future: (2011) (0)
- ARE THERE DIFFERENCES IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COUNSELING RATES AMONG ELIGIBLE PATIENTS HOSPITALIZED FOR HEART FAILURE? NATIONAL RESULTS FROM THE AMERICAN HEART ASSOCIATION’S GET WITH THE GUIDELINES- HEART FAILURE PROGRAM (2015) (0)
- Abstract 13542: Five-Year Outcomes in Patients Hospitalized With Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction in the Medicare Population (2017) (0)
- Distinguishing Severe from Nonsevere Valvular Aortic Stenosis in Patients with Depressed Left Ventricular Function and Low l'ransvalvular Gradients (1994) (0)
- Race and remedy [3] (2007) (0)
- Change In Health-related Quality of Life from Before To 1 Year After Surgery: Findings from Sustain-it (2020) (0)
- Abstract 15898: Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT): Baseline Caregiver Burden (2018) (0)
- Equity and the JAMA Network. (2021) (0)
- IMPROVING HEART FAILURE CARE:Strategies for Increasing Utilization of Beta-Blockade. In-Hospital Initiation of Beta-Blocker Therapy for Heart Failure (2002) (0)
- Steroid withdrawal improves late survival after heart transplantation: 10 year results (2002) (0)
- RELATIONSHIP BETWEEN CARDIOLOGY PRACTICE TEACHING STATUS AND IMPROVEMENT IN THE USE OF EVIDENCE-BASED THERAPY FOR HEART FAILURE: FINDINGS FROM IMPROVE HF (2010) (0)
- Does the Day of the Week Heart Failure Patients Are Admitted Influence Length of Stay or Mortality Risk? Findings from OPTIMIZE-HF (2007) (0)
- Cardiac Transplantation Trends And Outcomes Among Hispanic Patients (2023) (0)
- Failure with Renal Artery Ischemia (2011) (0)
- Abstract P247: Culturally Appropriate Cardiovascular Risk Management - Are Physicians Prepared for the Task? (2011) (0)
- Abstract 20566: Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes among Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge SBP (2016) (0)
- Response to BiDil's impact (2005) (0)
- Response to letters regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease". (2014) (0)
- Is History of Depression a Predictor of In-Hospital Treatment and Early Post-Discharge Outcomes in Patients with Heart Failure? A Report from OPTIMIZE-HF (2007) (0)
- 172 - Multicenter GRAHF2 Investigation (Genomic Response Analysis of Enhanced Heart Failure Therapy in African Americans): Objectives, Study Design and Initial 100 Subjects (2017) (0)
- Influence on the American Heart Association's Get With the Guidelines (GWTG) heart failure program on the quality of care for patients hospitalized with heart failure (2006) (0)
- Renal function is preserved following heart transplantation using IL-2 receptor blockade (2004) (0)
- Systems of health care (2012) (0)
- Nitric oxide role in heart failure: Pathophysiology and treatment. Discussion (2003) (0)
- Health-Related Quality of Life in Older Patients With Heart Failure From Before to Early After Advanced Surgical Therapies: Findings From the SUSTAIN-IT Study (2022) (0)
- Cardiac MRI Derived Extracellular Volume Fraction Sensitive to Acute Cardiac Allograft Rejection (2017) (0)
- In-hospital initiation of beta-blocker therapy for heart failure (2002) (0)
- Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction. (2023) (0)
- Routine chest CT screening in high risk cardiac transplant patients may improve survival (2005) (0)
- Abstract 14370: Rapidly Improving Adherence to Guideline-Directed Medical Therapies in Metropolitan Heart Failure Systems of Care (2020) (0)
- Impact of Frailty on Health-Related Quality of Life from before to 6 Months after Surgery: Findings from the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) Study (2019) (0)
- Bridging Strategies and their Association with Post Heart Transplant Outcomes (2019) (0)
- BNP Levels in Outpatients with Heart Failure: Frequency of Assessment, Relationship to Symptoms, Disease Severity, and HF Quality of Care Measures (2009) (0)
- Heart failure in special populations (2004) (0)
- Congestive Heart Failure Relationships between emerging measures of heart failure processes of care and clinical outcomes (2010) (0)
- THE IMPACT OF THE CURRENT VERSUS PRIOR CARDIAC RESYNCHRONIZATION GUIDELINES ON THE PROPORTION OF HOSPITALIZED HEART FAILURE PATIENTS ELIGIBLE FOR THERAPY (2017) (0)
- Abstract 17526: Dominant Negative TGF-{beta} Receptor-2 Gene Therapy Improves Left Atrial Strain by Decreasing Left Atrial Fibrosis in Experimental Heart Failure (2012) (0)
- Abstract 1287: The Impact of Different Ranking Methods for Hospital's Heart Failure Quality of Care: Results From the AHA' s Get With the Guidelines-Heart Failure Registry (2009) (0)
- Abstract 13165: Self-Reported Social Functioning is Responsive to Change in Functional Class in Patients With a Left Ventricular Assist Device: Findings From the Mechanical Circulatory Support Measures of Adjustment and Quality of Life Study (2020) (0)
- Immediate Past Chairman of the Board (2010) (0)
- Abstract P16: Cultural Competency to Reduce Stroke Disparities - A Patient Perspective (2011) (0)
- Failure Is Not an Option: Optimizing Care for Heart Failure Patients at the End of Life. (2019) (0)
- Change in Caregiver Health-Related Quality of Life from before to early after Surgery: Findings from the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) Study (2019) (0)
- PROFILE OF PATIENTS DISCHARGED AGAINST MEDICAL ADVICE: IS THERE A COST? (2020) (0)
- Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure (2022) (0)
- Abstract 15883: Home-Time as a Novel Post-Discharge Outcome for Patients Hospitalized With Heart Failure (2017) (0)
- Medicare Programs Underestimate Burden of Hospitalized Heart Failure (2017) (0)
- Admission Heart Rate and In-Hospital Outcomes in Patients Hospitalized for Heart Failure in Sinus Rhythm and Atrial Fibrillation (2012) (0)
- MEDICATION DOSING ADHERENCE IN OUTPATIENTS WITH HEART FAILURE FOLLOWING IMPLEMENTATION OF A PRACTICE-BASED PERFORMANCE IMPROVEMENT INTERVENTION: RESULTS FROM IMPROVE HF (2010) (0)
- Trends in the Use of Guideline-based Therapies Among Dialysis Patients Hospitalized with Heart Failure: Findings from Get With The Guidelines-Heart Failure (2015) (0)
- Noninvasive hemodynamic monitoring of the acute heart failure patient (2005) (0)
- Contemporary Trends and Comparison of Racial Differences in Hospitalizations of Adults With Congenital Heart Disease. (2022) (0)
- Abstract 18154: Association of Fibroblast Growth Factor-23 With Incident Hypertension in Young and Middle Aged Adults (2017) (0)
- Abstract 11071: Sustaining Quality of Life of the Aged: Transplant or Mechanical Support: Baseline Caregiver Quality of Life (2018) (0)
- Device Therapy for Left Ventricular Dysfunction (2010) (0)
- eyond Diuretics : Management of Volume Overload in cute Heart Failure Syndromes ames (2006) (0)
- Abstract 15: Quantifying Teamwork at Hospital Discharge for Readmissions Reduction: A Network Analytics Approach (2016) (0)
- Comment: Balancing gains and threats in cardiovascular care (2009) (0)
- Improving Quality of Care Through Disease Management Principles and Recommendations From the American Heart Association’s Expert Panel on Disease Management AHA (2004) (0)
- Addressing Cardiovascular Disease Disparities-Are We Getting Closer to the Truth? (2018) (0)
- Distribution and Correlates of Incident Heart Failure Risk in South Asian Americans: The MASALA Study. (2021) (0)
- Abstract 149: Care for Heart Failure Patients at the End of Life: Hospital Readmission and Mortality Amongst Heart Failure Patients Discharged to Hospice (2018) (0)
- Health-Related Quality of Life among Patients with Mechanical Circulatory Assistance: Clinician Perspectives (2013) (0)
- SCREENING OF PATIENTS WITH SIMPLE CLINICAL PARAMETERS EARLY IN HOSPITALIZATION IS HIGHLY SENSITIVE FOR DETECTION OF HEART FAILURE HOSPITALIZATION (2017) (0)
- 328: Increased LV Mass and Concentricity as Assessed by Cardiac MRI Are Associated with Increased Mortality in Cardiac Transplant Recipients (2010) (0)
- Atrial Fibrillation Increases Risk of Recurrent Heart Failure Readmissions in LVAD Patients (2018) (0)
- Sociodemographic Disparities in the GDMT Usage. (2023) (0)
- CONCURRENT SESSION 44: HLA ANTIBODIES IMPACT POST TRANSPLANTATION (2006) (0)
- Performance On Guideline Directed Medical Therapy Remains Low In A Cluster-randomized Trial: Results From CONNECT-HF (2022) (0)
- Rapidly Improving Health-Related Social Needs Assessment Through A National Collaborative (2023) (0)
- In search of a solution from the STICH trial. (2014) (0)
- EARLY PHYSICIAN FOLLOW-UP AND 30-DAY READMISSION AMONG MEDICARE BENEFICIARIES HOSPITALIZED WITH HEART FAILURE: DATA FROM OPTIMIZE-HF AND GWTG-HF (2010) (0)
- The challenges of data safety monitoring for a pragmatic study: Lessons from the ADAPTABLE study. (2022) (0)
- GENOMIC SCORE TO TARGET THERAPY WITH A FIXED DOSE COMBINATION OF HYDRALAZINE AND ISOSORBIDE DINITRATE (2016) (0)
- Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study (2022) (0)
- 009 - Excess Burden and Earlier Onset of Heart Failure with Obesity: The Paradox Explained (2017) (0)
- Abstract 17027: Generalizability of the US FDA Label for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in the GWTG-HF Registry (2020) (0)
- Abstract 18877: The Scope of Sacubitril/Valsartan Eligibility Post-Heart Failure Hospitalization: Findings From the Get With the Guidelines-Heart Failure Registry (2016) (0)
- The development and initial validation of the PROMIS®+HF‐27 and PROMIS+HF‐10 profiles (2022) (0)
- Contents (2020) (0)
- Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women". (2016) (0)
- Abstract 11455: Does Caregiver Burden Change from Before to 24 Months After Surgery: Findings from the Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support ( Sustain-it ) Study (2021) (0)
- Abstract 18426: Impact of Body Mass Index on Heart Failure With Preserved or Reduced Ejection Fraction: Outcomes According to Race and Ethnicity From Get With The Guidelines-Heart Failure (GWTG-HF) Registry (2015) (0)
- American Journal of Cardiology: Introduction (2005) (0)
- Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized with Heart Failure (2019) (0)
- Presentation of acute decompensated congestive heart failure in african-americans and their response to treatment with nesiritide (2002) (0)
- Abstract 15192: Implementation of the Hospital Readmissions Reduction Program, Readmissions, and Mortality in Heart Failure (2017) (0)
- Editor's Note Performance Measures: Better Outcomes, Not Better Grades (2017) (0)
- Is There a Role for Renal Denervation in the Treatment of Hypertension? (2023) (0)
- Abstract 1: The Impact of State Medicaid Expansions on Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure (2018) (0)
- Replacing Race With Social Determinants of Health in Risk Prediction-Getting It Right. (2022) (0)
- IMPACT OF MULTIDISCIPLINARY HEART FAILURE TRANSITIONAL CARE INTERVENTIONS ON DISPARITIES IN 30-DAY READMISSION RATES (2017) (0)
- Prevalence and Characteristics of Prolonged QRS Duration in Outpatients with Left Ventricular Systolic Dysfunction: An IMPROVE HF Analysis (2009) (0)
- VALIDATION OF A HEART FAILURE RISK ASSESSMENT TOOL IN A LARGE CONTEMPORARY ELECTRONIC HEALTH RECORD POPULATION (2019) (0)
- Contemporary Reviews in Cardiovascular Medicine Hydralazine and Isosorbide Dinitrate in Heart Failure Historical Perspective, Mechanisms, and Future Directions (2011) (0)
- Abstract 16863: Racial Differences in Atrial Fibrillation Prevalence and Anticoagulation Use (2012) (0)
- Heart Failure in Racial/Ethnic Groups (2009) (0)
- Practice Guidelines 2010 Accf/aha Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults a Report of the American College of Cardiology Foundation/american Heart Association Task Force on Practice Guidelines ¶ ¶recused from Voting on Section 2.4.2, Recommendations for Measurement of (0)
- Comparison of Medical Treatment in Outpatients Receiving Device Therapy for Systolic Dysfunction: A Report from IMPROVE HF (2008) (0)
- Initial BNP Level at Time of Referral Predicts Long-Term Mortality: A Retrospective Review of the UT Southwestern Heart Failure Database (2009) (0)
- FACTORS ASSOCIATED WITH IMPROVEMENT IN GUIDELINE-BASED USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ELIGIBLE HEART FAILURE PATIENTS BY IMPLEMENTING A PRACTICE-BASED PERFORMANCE IMPROVEMENT INTERVENTION: RESULTS FROM IMPROVE HF (2011) (0)
- Abstract 10420: Utilization of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure: Has it Changed and is it Associated With Patient Outcomes? (2015) (0)
- Heart Failure Care Transitions: A Queuing Theory Approach to Quantify the Impact of Vacation Periods on Discharge Clinic Wait Times (2016) (0)
- Prevalence and Clinical Characteristics of Patients Reporting Illicit Drug Use in the Acute Decompensated Heart Failure Population: An Acute Decompensated Heart Failure Registry-Emergency Module [ADHERE-EM] Report (2007) (0)
- Stroke: A Presidential Advisory From the American Heart Association/American Association/American Stroke Association to Reduce Death and Disability Due to Translating Evidence Into Practice: A Decade of Efforts by the American Heart (2010) (0)
- EFFECTS OF ACR GRADE 2R REJECTION TREATMENT ON MYOCARDIAL T1 AND T2 DURING YEAR ONE POST HEART TRANSPLANTATION (2020) (0)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2022) (0)
- Temporal Trends of Digoxin Use in Patients Hospitalized with Heart Failure: Analysis From the American Heart Association Get With The Guidelines - Heart Failure Registry (2015) (0)
This paper list is powered by the following services:
Other Resources About Clyde Yancy
What Schools Are Affiliated With Clyde Yancy?
Clyde Yancy is affiliated with the following schools:
